In the Department of Cardiothoracic Surgery, we believe the future of our field depends on optimal surgeon-scientist, basic scientist, and engineer partnerships. This is the model we practice and nurture daily across our basic, translational, and clinical research efforts. Our investigations span the full breadth of diseases and conditions addressed by cardiothoracic surgery including research programs in disease pathophysiology, vascular biology, surgical innovation, organ preservation, xenotransplantation, immunology, thoracic oncology, and cancer biology.
Basic and translational research laboratories of the Department of Cardiothoracic Surgery reside within several state-of-the-art facilities, including the McGowan Institute for Regenerative Medicine, the Thomas E. Starzl Institute, the Vascular Medicine Institute, and the Hillman Cancer Center. Our Department’s NIH funded portfolio expands to the realm of training grants, with current NHLBI funding supporting 4 post-doctoral scholars annually via T32 Training Program in Cardiothoracic Surgery Research.
Toward our goal of clinical impact through technology translation, our Department offers cardiothoracic surgical patients in our Western and Central Pennsylvania communities access to the latest clinical trials. Visit our faculty profiles to learn more about our cutting-edge research and training opportunities that are carving the future of cardiothoracic surgery.
